Cite
HARVARD Citation
Geoerger, B. et al. (2020). Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1–2 study. Lancet oncology. 21 (1), pp. 134-144. [Online].